Advanced Photonix, Inc. Reports Fiscal 2014 Revenues up 23%

ANN ARBOR, Mich., June 30, 2014 /PRNewswire/ -- Advanced Photonix, Inc.® (NYSE MKT: API) (the "Company") today reported results for the fourth quarter and year ended March 31, 2014.

Financial Highlights for the Fourth Quarter and Fiscal Year Ended March 31, 2014

  • Net sales for the quarter were $7.0 million, an increase of $1.0 million or 16% from the fourth quarter ended March 31, 2014. Sequentially, revenues were down 6% relative to the third quarter of fiscal 2014.
  • Net sales for the current fiscal year were $29.0 million, an increase of 23% over the prior year. The increase was attributable to test and measurement revenues associated with the Silonex net asset purchase in March 2013 and strong demand in telecommunication market sales.
  • Gross profit margin for Q4 2014 was 29% of sales compared to 36% for the quarter ended March 31, 2013. An unfavorable mix shift out of Comtest and Terahertz contract sales explained the rate change.
  • Gross profit margin for the fiscal year 2014 was 33% relative to 37% in the prior year. The Company incurred approximately $667,000 in one time charges in fiscal 2014 associated with the shutdown of it silicon photodiode fabrication activities.
  • Current quarter net loss was $1.1 million or $0.04 per diluted share, as compared to a quarterly net loss of $1.1 million or $0.03 per diluted share for the quarter ended March 31, 2013.
  • Net loss for the fiscal year 2014 was $4.3 million or $0.14 per diluted share, as compared to a loss of $4.4 million, or $0.14 per diluted share for the prior year period.
  • The Non-GAAP net loss for the fourth quarter of fiscal 2013 was $887,000 or $0.03 per diluted share, as compared to a Non-GAAP loss of $775,000, or $.02 per diluted share, for the fourth quarter last year. The Company reported full-year Non-GAAP net loss of $2.1 million, or $0.07 per diluted share, as compared to a Non-GAAP loss of $3.1 million, or $0.10 per diluted share, for the comparable prior year period.
  • Adjusted EBITDA (which is defined as GAAP earnings before interest, taxes, depreciation, amortization and stock compensation), was a negative $593,000 for the fourth quarter of fiscal 2014 as compared to negative adjusted EBITDA of $572,000 for the quarter ended March 31, 2013. For the fiscal year 2014, the Company reported negative adjusted EBITDA of $846,000 as compared to a negative adjusted EBITDA of $2.2 million for the comparable prior year period.

Operating Expenses

The Company's total operating expenses for the quarter were $3.1 million, down about $216,000 from the fourth quarter last year. As a percent of revenue, total operating expenses were 44% compared to 54% for the fourth quarter last year. For the year, total operating expenses were $13.0 million, or 45% of revenue, compared to $13.2 million, or 56% of revenue last year.

Balance Sheet

The Company finished the year with $120,000 in cash compared to $619,000 as of March 31, 2013 due primarily to the losses that were funded during the year. Net working capital as of March 31, 2014 was $1.7 million and the Company had the ability to borrow up to $2.0 million on the Company's line of credit to provide any needed working capital. In June 2014, the Company obtained approximately $2.9 million in net cash proceeds from a firm underwritten Class A Common Stock placement using B Riley & Co. The Company believes this capital will be more than sufficient to provide the needed funding to satisfy working capital needs over the next year.

Richard Kurtz, President and Chief Executive Officer, commented, "Last year was a transition year. The acquisition of the Silonex business brought about $3.8 million in new test and measurement revenues and resolution of supply chain constraints in the HSOR product line helped grow the Company by an added $4.0 million. The military spending fall off for the year was the big headwind with the second half especially weak. That trend though is reversing given recent contract awards which bodes well for a stronger fiscal 2015. With all three of our key markets looking to grow in fiscal 2015, the Company expects overall growth to exceed 20%."

Conference Call

Participating in the call will be Richard Kurtz (CEO and Director), Rob Risser (COO and Director), and Jeff Anderson (CFO). The conference call will be webcast live and will be accessible at http://www.videonewswire.com/event.asp?id=99887. Participants can dial into the conference call at 877.870.4263 (412.317.0790 for international and 855.669.9657 for Canada). The conference call will last approximately one hour and will end with a question and answer period.

An audio replay of the call will be available shortly thereafter on the same day and will remain on-line until July 30, 2014. The replay will be available in the investors section of API's website at www.advancedphotonix.com.

Forward-looking Statements:

The information contained herein includes forward looking statements that are based on assumptions that management believes to be reasonable but are subject to inherent uncertainties and risks including, but not limited to, unforeseen technological obstacles which may prevent or slow the development and/or manufacture of new products; potential problems with the integration of the acquired company and its technology and possible inability to achieve expected synergies; obstacles to successfully combining product offerings and lack of customer acceptance of such offerings; limited (or slower than anticipated) customer acceptance of new products which have been and are being developed by the Company; and a decline in the general demand for optoelectronic products; and the risk factors listed from time to time in the Company's' Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and any subsequent SEC filings. The Company assumes no obligation to update forward-looking statements contained in this release to reflect new information or future events or developments.

CONDENSED CONSOLIDATED BALANCE SHEET




ASSETS

March 31, 2013

March 31, 2014

Current assets



Cash and cash equivalents

$             619,000

$             120,000

Receivables, net

4,988,000

5,085,000

Inventories

3,905,000

4,749,000

Prepaid expenses and other current assets

795,000

444,000

Total current assets

10,307,000

10,398,000

Net equipment and leasehold improvements, net

3,415,000

2,144,000

Goodwill

4,579,000

4,579,000

Intangible and patents, net

3,686,000

2,942,000

Other assets

229,000

138,000

Total assets

$        22,216,000

$        20,201,000




LIABILITIES AND SHAREHOLDERS' EQUITY



Current liabilities



Accounts payable and accrued expenses

$          3,127,000

$          4,113,000

Accrued compensation

729,000

701,000

Current portion of long-term debt – bank term loan

333,000

306,000

Current portion of long-term debt – bank line of credit

--

2,147,000

Current portion of long-term debt – PFG

714,000

714,000

Current portion of long-term debt – MEDC

553,000

654,000

Current portion of capital leases

--

20,000

Total current liabilities

5,456,000

8,655,000

Long term debt, less current portion – bank term loan

334,000

--

Long term debt, net of debt discount and current – PFG

1,322,000

794,000

Long term debt, less current portion – MEDC/MSF

377,000

--

Long term debt, capital lease

--

36,000

Warrant liability

292,000

409,000

Total liabilities

7,781,000

9,894,000




Shareholders' equity



Class A common stock, $.001 par value, 100,000,000 shares authorized; March 31, 2013 – 31,158,347 shares issued and outstanding; March 31, 2014– 31,203,213 shares issued and outstanding

31,000

31,000

Additional paid-in capital

58,616,000

58,752,000

Accumulated deficit

(44,212,000)

(48,476,000)

Total shareholders' equity

14,435,000

10,307,000

Total liabilities and shareholders' equity

$        22,216,000

$        20,201,000

 

CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)






Three months ended


Twelve months ended


March 31, 2013


March 31, 2014


March 31, 2013


March 31, 2014

Sales, net

$        6,013,000


$        6,977,000


$     23,649,000


$     29,041,000

Cost of products sold

3,858,000


4,973,000


14,823,000


19,433,000

Gross profit

2,155,000


2,004,000


8,826,000


9,608,000









Operating expenses








Research, development and engineering

1,412,000


1,085,000


5,683,000


4,975,000

Sales and marketing

565,000


695,000


2,093,000


2,562,000

General and administrative

995,000


1,021,000


4,254,000


4,482,000

Amortization expense

305,000


260,000


1,181,000


1,029,000

Total operating expenses

3,277,000


3,061,000


13,211,000


13,048,000

Loss from operations

(1,122,000)


(1,057,000)


(4,385,000)


(3,440,000)









Other income (expense)








Net interest expense

(102,000)


(166,000)


(192,000)


(644,000)

Change in fair value of warrant liability

142,000


96,000


168,000


(117,000)

Other income (expense)

1,000


(16,000)


22,000


(63,000)

Total other income (expense)

41,000


(86,000)


(2,000)


(824,000)

Loss before benefit from income taxes

(1,081,000)


(1,143,000)


(4,387,000)


(4,264,000)









Benefit for income taxes

--


--


--


--









Net loss

$    (1,081,000)


$   (1,143,000)


$     (4,387,000)


$     (4,264,000)









Basic and diluted loss per share

$             (0.03)


$            (0.04)


$              (0.14)


$              (0.14)









Weighted average common shares outstanding

31,161,000


31,240,000


31,161,000


31,227,000









Non-GAAP Financial Measures

The Company provides Non-GAAP Net Income, EBITDA and adjusted EBITDA as supplemental financial information regarding the Company's operational performance. These Non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. Non-GAAP Net Income, EBITDA and adjusted EBITDA should not be considered in isolation from or as a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from similar measures used by other companies. Reconciliation of Non-GAAP Net Income, EBITDA and adjusted EBITDA to GAAP net income and loss are set forth in the financial schedule section below.

RECONCILIATION OF NON-GAAP LOSS TO GAAP LOSS






Three months ended


Twelve months ended


March 31, 2013


March 31, 2014


March 31, 2013


March 31, 2014

Net loss

$    (1,081,000)


$    (1,143,000)


$    (4,387,000)


$    (4,264,000)

Adjustments:








Change in warrant fair value

(142,000)


(96,000)


(168,000)


117,000

Amortization - intangibles/patents

305,000


260,000


1,181,000


1,029,000

Accelerated depreciation on fab shutdown

--


--


--


608,000

Non-cash interest expense

--


63,000


--


264,000

Acquisition related expenses

100,000


--


100,000


--

Stock option compensation expense

43,000


29,000


167,000


139,000

Subtotal  s

306,000


256,000


1,280,000


2,157,000

Non-GAAP income (loss)

$     (775,000)


$     (887,000)


$     (3,107,000)


$     (2,107,000)









Basic and diluted loss per share

$           (0.02)


$           (0.03)


$             (0.10)


$             (0.07)

Weighted average common shares outstanding

31,161,000


31,240,000


31,161,000


31,227,000









 

RECONCILIATION OF EBITDA AND ADJUSTED EBITDA TO GAAP LOSS






Three months ended


Twelve months ended


March 31, 2013


March 31, 2014


March 31, 2013


March 31, 2014

Net loss

$       (1,081,000)


$       (1,143,000)


$    (4,387,000)


$    (4,264,000)

Adjustments:








Net interest expense (income)

102,000


166,000


192,000


644,000

Warrant fair value adjustment

(142,000)


(96,000)


(168,000)


117,000

Depreciation expense

201,000


191,000


785,000


1,489,000

Amortization

305,000


260,000


1,181,000


1,029,000

Subtotal

466,000


521,000


1,990,000


3,279,000

EBITDA

$        (615,000)


$        (622,000)


$    (2,397,000)


$       (985,000)

Stock compensation

43,000


29,000


167,000


139,000

Adjusted EBITDA

$        (572,000)


$        (593,000)


$    (2,230,000)


$       (846,000)









About Advanced Photonix, Inc.

Advanced Photonix, Inc. ® (NYSE MKT: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical receivers and terahertz instrumentation for telecom, homeland security, military, medical and industrial markets. With our patented technology and state-of-the-art manufacturing we offer industry leading performance, exceptional quality, and high value added products to our OEM customer base. For more information visit us on the web at www.advancedphotonix.com.

CONTACT: ir@advancedphotonix.com

Logo - http://photos.prnewswire.com/prnh/20130304/LA69982LOGO

SOURCE Advanced Photonix, Inc.



RELATED LINKS
http://www.advancedphotonix.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.